Levetiracetam synergizes with gabapentin, pregabalin, duloxetine and selected antioxidants in a mouse diabetic painful neuropathy model

[1] Alabdali M(2015)Choosing drugs for the treatment of diabetic neuropathy Expert Opin Pharmacother 16 1805-1814

[2] Qrimli M(2014)Comparison of the effects of single doses of elcatonin and pregabalin on oxaliplatin-induced cold and mechanical allodynia in rats Biol Pharm Bull 37 322-326

[3] Barnett C(2003)Antihyperalgesic effect of levetiracetam in neuropathic pain models in rats Eur J Pharmacol 473 27-33

[4] Abraham A(2010)European Federation of Neurological Societies: EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision Eur J Neurol 17 1113-1e88

[5] Breiner A(2008)Coenzyme Q(10) and alpha-lipoic acid supplementation in diabetic rats: conduction velocity distributions Methods Find Exp Clin Pharmacol 30 367-374

[6] Katzberg HD(1998)Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial JAMA 280 1831-1836

[7] Aljaafari D(2016)Long-term cost-effectiveness of initiating treatment for painful diabetic neuropathy with pregabalin, duloxetine, gabapentin, or desipramine Pain 157 203-213

[8] Albulaihe H(2006)Levetiracetam in the prophylaxis of migraine with aura: a 6-month open-label study Clin Neuropharmacol 29 338-342

[9] Perkins BA(2011)American Academy of Neurology; American Association of Neuromuscular and Electrodiagnostic Medicine; American Academy of Physical Medicine and Rehabilitation: evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation Neurology 76 1758-1765

[10] Bril V(2008)Low-dose aspirin prevents age-related endothelial dysfunction in a mouse model of physiological aging Am J Physiol Heart Circ Physiol 294 H1562-H1570

[1] Alabdali M(2015)Choosing drugs for the treatment of diabetic neuropathy Expert Opin Pharmacother 16 1805-1814

[2] Qrimli M(2014)Comparison of the effects of single doses of elcatonin and pregabalin on oxaliplatin-induced cold and mechanical allodynia in rats Biol Pharm Bull 37 322-326

[3] Barnett C(2003)Antihyperalgesic effect of levetiracetam in neuropathic pain models in rats Eur J Pharmacol 473 27-33

[4] Abraham A(2010)European Federation of Neurological Societies: EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision Eur J Neurol 17 1113-1e88

[5] Breiner A(2008)Coenzyme Q(10) and alpha-lipoic acid supplementation in diabetic rats: conduction velocity distributions Methods Find Exp Clin Pharmacol 30 367-374

[6] Katzberg HD(1998)Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial JAMA 280 1831-1836

[7] Aljaafari D(2016)Long-term cost-effectiveness of initiating treatment for painful diabetic neuropathy with pregabalin, duloxetine, gabapentin, or desipramine Pain 157 203-213

[8] Albulaihe H(2006)Levetiracetam in the prophylaxis of migraine with aura: a 6-month open-label study Clin Neuropharmacol 29 338-342

[9] Perkins BA(2011)American Academy of Neurology; American Association of Neuromuscular and Electrodiagnostic Medicine; American Academy of Physical Medicine and Rehabilitation: evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation Neurology 76 1758-1765

[10] Bril V(2008)Low-dose aspirin prevents age-related endothelial dysfunction in a mouse model of physiological aging Am J Physiol Heart Circ Physiol 294 H1562-H1570